Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine
Status:
Completed
Trial end date:
2021-01-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of co-administrated
Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine in patients with primary
hypercholesterolemia and essential hypertension.